KCT0006558已完成未知
A randomized, double-blind, controlled (Placebo) comparative clinical trial to evaluate the functionality and safety of swallow's nest extract for improving skin wrinkles, elasticity, moisturizing and whitening in adult women
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 104
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 40(Year) 至 60(Year)（—）
- 性别
- Female
入选标准
- •1) Adult women aged 40 or more and less than 60 years of age
- •2) Subjects with wrinkles around the eyes and a global photo damage score of 2-6
- •3) Subjects who are not currently taking health functional foods or similar products for the purpose of improving skin health such as skin wrinkles, elasticity, moisturizing, and whitening
- •4) Subjects who have understood the purpose, contents, and possible adverse reactions of the study and have voluntarily signed a written consent
排除标准
- •1) Subjects with severe acute kidney disease, heart disease, liver disease, or other chronic disease that may affect the test results within the last 6 months
- •2) Subjects with a history of stroke or transient ischemic heart attack
- •3) Subjects with a history of malignancy or lung disease within 5 years of screening
- •4) Patients with uncontrolled hypertension (systolic blood pressure greater than 160 mmHg or diastolic blood pressure greater than 100 mmHg, measured after 10 minutes of rest) or uncontrolled diabetes patients (fasting blood sugar greater than 180 mg/dL)
- •5) Subjects with an important neurological or psychological history or currently suffering from diseases (schizophrenia, epilepsy, alcoholism, drug addiction, anorexia, bulimia, etc.)
- •6) Subjects with skin abnormalities such as spots, acne, tattoos, scars, erythema, capillary dilatation, and burn marks on the measurement site
- •7) Subjects who have used oral or applied retinoids/steroids within 6 months prior to the start of the test, or who have undergone skin peeling or skin wrinkle removal procedures
- •8) Subjects who have used functional cosmetics for wrinkle improvement (retinoids, AHA, etc.), highly moisturizing/elastic cosmetics, or skin care devices (LED mask, ion booster, etc.) within 2 weeks of screening
- •9) Subjects with eczematous skin diseases (eczema, atopic dermatitis, etc.) or infectious skin diseases
- •10) Subjects with allergic specific constitution (food, pollen, etc.) or hypersensitivity
- •11) Subjects with irritation or allergy to cosmetics, pharmaceuticals, health functional foods, and daily exposure to sunlight
- •12) Subjects with a history of hypersensitivity (allergy) to swallow's nest extract
- •13) Pregnant women, lactating women, those planning to become pregnant, and those taking contraceptives or female hormones
- •14) Subjects receiving other prohibited treatment (insulin, antidepressant, antiserotonin, barbiturate, antipsychotic, drug with potential for abuse, absorption inhibitor, appetite suppressant, etc.)
- •15) Subjects who have used steroid-containing skin external agents for 2 weeks or more for the treatment of skin diseases
- •16) Subjects who have taken steroids (oral and injection), hormones, or drugs that affect absorption, distribution, metabolism, and excretion of drugs within the past 3 months and drugs that may affect the skin
- •17) Subjects with abnormalities in the general opinion of the specialist as a result of blood and urine tests (AST, ALT, ALP, ?-GT, and total bilirubin levels are more than 3 times the upper limit reference value (UNL), and serum creatinine levels are the upper limit reference value (UNL)) more than twice the
- •18) Subjects within 3 months of participating in the same trial
- •19) Other subjects who are considered unsuitable for the study at the discretion of the principal investigator
研究者
相似试验
已完成
3 期
clinical study of Diabetic Support Product in Subjects suffering from Type II DiabetesCTRI/2022/01/039179Mr Kamlesh Thummar156
进行中（未招募）
不适用
A clinical trial in subjects who suffer from hay fever to see the effects of the study medication, SB-705498, when taken on its own or in conjunction with a background therapy, Fluticasone Propionate, on the symptoms triggered by an allergen challenge chamber session.EUCTR2011-000115-11-ATGlaxoSmithKline Research and Development Ltd72
已完成
2 期
A clinical trial to evaluate the effect preoperative intranasal Dexmedetomidine to decrease hypertensive response of laryngoscopy and endotracheal intubation in elective lumber spine surgery.CTRI/2016/10/007384Bangur Institute of Neurosciences Kolkata70
尚未招募
不适用
A Clinical study to evaluate the effect of ASFP001/21 and SMXP001/22 on improvement in quality of life in healthy volunteers with mild to moderate functional dyspepsia symptoms.CTRI/2022/07/044075Akay Natural Ingredients Pvt Ltd
进行中（未招募）
1 期
A study to investigate the efficacy of PARENTIDE cream, a new drug for the treatment of itchEUCTR2022-001374-60-ESBCN Peptides45